SIGNOR-PC	Prostate Cancer	MYC	factor	protein	P01106	UNIPROT	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606		BTO:0001103							21408055	f		andrea cerquone perpetuini	We have demonstrated that following muscle damage, phosphorylated STAT3 (p-STAT3) in SCs increases early (within one hour), inducing downstream target genes (i.e. GP130 and SOCS3), which further regulate the increase in STAT3 production and response (as induced via IL-6), leading to increased cMyc expression, which drives cell proliferation	SIGNOR-255414	0.7	
SIGNOR-PC	Prostate Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation	Thr308	KDGATMKtFCGTPEY	10116		BTO:0000142							10226025	t		lperfetto	Protein kinase B (PKB) is activated by phosphorylation of Thr308 and of Ser473. Thr308 is phosphorylated by the 3-phosphoinositide-dependent protein kinase-1 (PDK1) but the identity of the kinase that phosphorylates Ser473 (provisionally termed PDK2) is unknown.	SIGNOR-244421	0.787	
SIGNOR-PC	Prostate Cancer	SPOP		protein	O43791	UNIPROT	NCOA3	factor	protein	Q9Y6Q9	UNIPROT	down-regulates quantity by destabilization	binding			9606									24239470	t		miannu	Mutations in SPOP represent the most common point mutations in primary prostate cancer,with recurrent mutations in SPOP in 6% to 15% of multiple independent cohorts.  Wild-type SPOP will bind and promote the degradation of SRC-3,whereas prostate cancer–derived SPOP mutants lose this ability,leading to increased androgen signaling in certain model systems.	SIGNOR-251529	0.474	
SIGNOR-PC	Prostate Cancer	MYC	factor	protein	P01106	UNIPROT	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									9552384	f		gcesareni	C-myc has emerged as one of the central regulators of mammalian cell proliferation.	SIGNOR-56572	0.7	
SIGNOR-PC	Prostate Cancer	MET	receptor	protein	P08581	UNIPROT	Metastasis	phenotypesList	phenotype	SIGNOR-PH107	SIGNOR	up-regulates				9606	BTO:0001033								22035268	f		miannu	C-Met expression and activation appears to be one of the common mechanisms of resistance to other targeted therapies. Given these multiple roles of c-Met in prostate cancer, several c-Met inhibitors have been developed. Evidence to date suggests that aberrant activation of the HGF/c-Met axis in prostate cancer epithelial cells appears to be a relatively late event in tumor progression. C-Met expression increases in advanced stages of the disease, with the highest expression observed in bone metastases.	SIGNOR-263658	0.7	
SIGNOR-PC	Prostate Cancer	PTEN		protein	P60484	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	down-regulates activity				9606	BTO:0001271								20596030	f		lperfetto	Exposure of eol-1r cells to imatinib failed to dephosphorylate akt, erk and stat5, although pdgfralpha was effectively inactivated. The forced expression of pten negatively regulated these signal pathways and sensitized eol-1r cells to imatinib.	SIGNOR-166478	0.613	
SIGNOR-PC	Prostate Cancer	AR		protein	P10275	UNIPROT	Survival	phenotypesList	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									15861399	f		miannu	AR homodimers recruit a panoply of factors including coactivators and mediator proteins whose enzymatic activities promote chromatin remodeling and transcriptional regulation of target genes leading to cell differentiation, survival, and proliferation	SIGNOR-251539	0.7	
SIGNOR-PC	Prostate Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation	Thr308	KDGATMKtFCGTPEY	10090									12808134	t		lperfetto	Akt1 and akt2 are phosphorylated and activated by the protein kinase pdk1 at thr-308 or thr-309, respectively, in the activation t-loop, and further activation occurs through phosphorylation at ser-473 or ser-474, respectively. In this paper, we demonstrate that this is indeed the case, and report the purification and initial characterization of a 3 phosphoinositide-dependent protein kinase, pdk1, which activates pkb by phosphorylating it at thr308. Akt is directly phosphorylated and activated by pdk1. Akt/pkb activation requires the phosphorylation of thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (pdk1).	SIGNOR-134477	0.787	
SIGNOR-PC	Prostate Cancer	TP53	factor	protein	P04637	UNIPROT	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	down-regulates				9606	BTO:0000452								7667317	f			P53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts	SIGNOR-255669	0.7	
SIGNOR-PC	Prostate Cancer	AR		protein	P10275	UNIPROT	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									15861399	f		miannu	AR homodimers recruit a panoply of factors including coactivators and mediator proteins whose enzymatic activities promote chromatin remodeling and transcriptional regulation of target genes leading to cell differentiation, survival, and proliferation	SIGNOR-251540	0.7	
SIGNOR-PC	Prostate Cancer	PIK3CA		protein	P42336	UNIPROT	Survival	phenotypesList	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9534	BTO:0004055								14665640	f		lperfetto	Signal transduction pathways triggered by Tie2 have been extensively examined. Tyr-1101of Tie2 directly associates in a phosphotyrosine (pTyr)-dependent manner with the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase, which in turn activate PI 3-kinase, leading to cell motility and survival	SIGNOR-242649	0.7	
SIGNOR-PC	Prostate Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotypesList	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606	BTO:0000830								15526160	f		miannu	 c-Kit promotes survival via PI3-kinase-dependent activation of Akt and phosphorylation of Bad, a pro-apoptotic molecule, at S136 in vivo. 	SIGNOR-254952	0.7	
SIGNOR-PC	Prostate Cancer	PTEN		protein	P60484	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	down-regulates activity				9606	BTO:0001332								19903340	f		lperfetto	PTEN-mediated suppression of the PI3K/AKT pathway is well established, accumulating evidence suggests that nuclear PTEN also plays a critical role in tumor suppression	SIGNOR-244439	0.613	
SIGNOR-PC	Prostate Cancer	PTEN		protein	P60484	UNIPROT	PIK3CA		protein	P42336	UNIPROT	down-regulates activity				9606									18794881	f		lperfetto	The pten tumour suppressor is a lipid and protein phosphatase that inhibits phosphoinositide 3-kinase (pi3k)-dependent by dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (ptdinsp(3)).	SIGNOR-209856	0.683	
SIGNOR-PC	Prostate Cancer	NKX3-1	factor	protein	Q99801	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	down-regulates activity				9606									16697957	t		miannu	NKX3.1 negatively regulates AKT activity in an AR-dependent manner	SIGNOR-251552	0.49	
SIGNOR-PC	Prostate Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	Survival	phenotypesList	phenotype	SIGNOR-PH13	SIGNOR	up-regulates				9606									16288293	f		miannu	Akt promotes both cell growth and cell survival by inactivating its downstream substrates including GSK3, BAD, FOXO and TSC2.	SIGNOR-251550	0.7	
SIGNOR-PC	Prostate Cancer	MYC	factor	protein	P01106	UNIPROT	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090		BTO:0000724							7882978	f		irozzo	These observations indicate that continued late-stage expression of L-myc affected differentiation processes directly, rather than indirectly through deregulated growth control, whereas constitutive c-myc expression inhibited proliferative arrest, but did not appear to disturb differentiation.	SIGNOR-259110	0.7	
SIGNOR-PC	Prostate Cancer	PTEN		protein	P60484	UNIPROT	PIP3	receptor	smallmolecule	CHEBI:16618	ChEBI	down-regulates quantity	chemical modification			9606									11875759	t		lperfetto	PTEN dephosphorylates PI3P, lowering its cellular levels and resulting in the down-regulation of AKT.	SIGNOR-228145	0.8	
SIGNOR-PC	Prostate Cancer	ERG		protein	P11308	UNIPROT	EZH2	factor	protein	Q15910	UNIPROT	up-regulates quantity by expression	transcriptional regulation			9606									25277175	f		miannu	Increased expression of ERG or other ETS factors under control of androgen responsive promoter (TMPRSS2) is an inevitable consequence of the fusion events, and it activates transcriptional program that contributes to oncogenesis by upregulating expression of, among others, MYC, EZH2 and SOX9 and repressing NKX3.	SIGNOR-251555	0.359	
SIGNOR-PC	Prostate Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	AR		protein	P10275	UNIPROT	down-regulates	phosphorylation	Ser215	SGRAREAsGAPTSSK	9606	BTO:0000938								17470458	t		lperfetto	The work presented here is the first demonstration that phosphorylation at s215 and s792 by akt regulates ligand binding, and the subcellular distribution of the receptor	SIGNOR-244140	0.2	
SIGNOR-PC	Prostate Cancer	MDM2		protein	Q00987	UNIPROT	TP53	factor	protein	P04637	UNIPROT	down-regulates quantity by destabilization	ubiquitination			9606									22337874	t		lperfetto	The E3 ubiquitin ligase, MDM2, uses a dual-site mechanism to ubiquitinate and degrade the tumor suppressor protein p53, involving interactions with the N-terminal hydrophobic pocket and the acidic domain of MDM2.	SIGNOR-196116	0.969	
SIGNOR-PC	Prostate Cancer	UBE2C		protein	O00762	UNIPROT	Mitotic_checkpoint	phenotypesList	phenotype	SIGNOR-PH28	SIGNOR	down-regulates				9606									19632176	f		miannu	The evolution of prostate cancer from an androgen-dependent state (ADPCa) to one that is androgen-independent (AIPCa) marks its lethal progression. The androgen receptor (AR) is essential in both, though its function in AIPCa is poorly understood. We have defined the direct AR-dependent target genes in both AIPCa and ADPCa by generating AR-dependent gene expression profiles and AR cistromes. In contrast to ADPCa, AR selectively up-regulates M-phase cell cycle genes in AIPCa including UBE2C, a gene that inactivates the M-phase checkpoint. 	SIGNOR-251544	0.7	
SIGNOR-PC	Prostate Cancer	NCOA2	factor	protein	Q15596	UNIPROT	AR		protein	P10275	UNIPROT	up-regulates activity	binding			9606									24239470	t		miannu	The NCOA2 gene encodes a transcriptional coactivator (SRC-2) that modulates gene expression by hormone receptors, including AR. NCOA2 is both amplified and rarely mutated in prostate cancers, with higher NCOA2 levels resulting in increased androgen signaling readout. Furthermore, as mentioned previously, SRC-3, a close homolog encoded by NCOA3, is a substrate of SPOP whose protein levels are increased by SPOP mutation, potentially linking these common point mutations to the androgen axis	SIGNOR-251530	0.911	
SIGNOR-PC	Prostate Cancer	MDM2		protein	Q00987	UNIPROT	TP53	factor	protein	P04637	UNIPROT	down-regulates quantity by destabilization	ubiquitination			9606									23150757	t		lperfetto	Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity	SIGNOR-199371	0.969	
SIGNOR-PC	Prostate Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				9606									24743741	f			Activation of PDGFRα stimulates proliferation of PDGFRα(+) cells through PI3K-Akt and MEK2-MAPK signaling pathways, and aberrant accumulation of PDGFRα(+) cells was conspicuous in muscles of patients with both genetic and non-genetic muscle diseases.	SIGNOR-257606	0.7	
SIGNOR-PC	Prostate Cancer	TMPRSS2	receptor	protein	O15393	UNIPROT	HGF	extracellular	protein	P14210	UNIPROT	up-regulates quantity by expression	transcriptional regulation			9606									25122198	t		miannu	 we identified pro-hepatocyte growth factor (HGF) as a TMPRSS2 substrate and confirmed that HGF and it’s cognate receptor c-Met are activated in prostate cancers expressing TMPRSS2, a finding that also associated with the acquisition of a pro-invasive mesenchymal gene expression program.	SIGNOR-263657	0.2	
SIGNOR-PC	Prostate Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	MDM2		protein	Q00987	UNIPROT	up-regulates activity	phosphorylation	Ser186	RQRKRHKsDSISLSF	9606									11504915	t		lperfetto	Mitogen-induced activation of phosphatidylinositol 3-kinase (pi3-kinase) and its downstream target, the akt/pkb serine-threonine kinase, results in phosphorylation of mdm2 on serine 166 and serine 186. Phosphorylation on these sites is necessary for translocation of mdm2 from the cytoplasm into the nucleus.Both akt expression and serum treatment induced phosphorylation of mdm2 at ser186.	SIGNOR-244292	0.2	
SIGNOR-PC	Prostate Cancer	NKX3-1	factor	protein	Q99801	UNIPROT	TP53	factor	protein	P04637	UNIPROT	up-regulates quantity by stabilization				9606									16697957	f		miannu	NKX3.1 stabilizes p53.NKX3.1 can physically associate with HDAC1 and promotes p53 acetylation by recruiting HDAC1 from p53-MDM2-HDAC1 complex	SIGNOR-251548	0.329	
SIGNOR-PC	Prostate Cancer	TP53	factor	protein	P04637	UNIPROT	MDM2		protein	Q00987	UNIPROT	up-regulates quantity by expression	transcriptional regulation			10090									7958853	f		gcesareni	The p53 tumor suppressor protein trans-activates mdm2 itself, which is therefore considered a component of a p53 negative feedback loop.	SIGNOR-34962	0.969	
SIGNOR-PC	Prostate Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates	phosphorylation			9606									21798082	t		lperfetto	Positive feedback involves mtorc2, which phosphorylates akt at serine 473, a phosphorylation required for maximum activation of akt in addition to phosphorylation at threonine 308 by pdk1.	SIGNOR-244396	0.787	
SIGNOR-PC	Prostate Cancer	PPARG	factor	protein	P37231	UNIPROT	PTEN		protein	P60484	UNIPROT	down-regulates activity				9606									23128507	t	PAX8-PPARγ fusion protein	miannu	The PAX8-PPARγ rearrangement leads to strong induction of the PPARγ protein and the consequent abrogation of the normal PPARγ function. PPARγ overexpression abolishes the PTEN-inhibitory effect on immunoactive AKT, which in turn induces the PI3K signaling pathway.	SIGNOR-251997	0.42	
SIGNOR-PC	Prostate Cancer	NCOA2	factor	protein	Q15596	UNIPROT	PPARG	factor	protein	P37231	UNIPROT	up-regulates	binding			9606									18584035	t		gcesareni	Collectively, our data provide the first evidence that erbeta-deficiency protects against diet-induced ir and glucose intolerance which involves an augmented ppargamma signaling in adipose tissue. Moreover, our data suggest that the coactivators src1 and tif2 are involved in this interaction.	SIGNOR-179175	0.802	
SIGNOR-PC	Prostate Cancer	AR		protein	P10275	UNIPROT	UBE2C		protein	O00762	UNIPROT	up-regulates quantity by expression	transcriptional regulation			9606									19632176	t		miannu	The evolution of prostate cancer from an androgen-dependent state (ADPCa) to one that is androgen-independent (AIPCa) marks its lethal progression. The androgen receptor (AR) is essential in both, though its function in AIPCa is poorly understood. We have defined the direct AR-dependent target genes in both AIPCa and ADPCa by generating AR-dependent gene expression profiles and AR cistromes. In contrast to ADPCa, AR selectively up-regulates M-phase cell cycle genes in AIPCa including UBE2C, a gene that inactivates the M-phase checkpoint. 	SIGNOR-251543	0.374	
SIGNOR-PC	Prostate Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation			9606									15743829	t		lperfetto	3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates the activation loop of a number of protein serine/threonine kinases of the AGC kinase superfamily, including protein kinase B (PKB; also called Akt),	SIGNOR-244469	0.787	
SIGNOR-PC	Prostate Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	Proliferation	phenotypesList	phenotype	SIGNOR-PH4	SIGNOR	up-regulates				10090									16982699	f			Protein kinase B (PKB/Akt) is an important modulator of insulin signaling, cell proliferation, and survival. Using small interfering RNA duplexes in nontransformed mammalian cells, we show that only Akt1 is essential for cell proliferation	SIGNOR-254353	0.7	
SIGNOR-PC	Prostate Cancer	NCOA2	factor	protein	Q15596	UNIPROT	AR		protein	P10275	UNIPROT	up-regulates activity	binding			9606									24239470	t		miannu	The NCOA2 gene encodes a transcriptional coactivator (SRC-2) that modulates gene expression by hormone receptors, including AR. NCOA2 is both amplified and rarely mutated in prostate cancers, with higher NCOA2 levels resulting in increased androgen signaling readout. Furthermore, as mentioned previously, SRC-3, a close homolog encoded by NCOA3, is a substrate of SPOP whose protein levels are increased by SPOP mutation, potentially linking these common point mutations to the androgen axis	SIGNOR-251531	0.911	
SIGNOR-PC	Prostate Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	AR		protein	P10275	UNIPROT	down-regulates activity	phosphorylation	Ser792	CVRMRHLsQEFGWLQ	9534	BTO:0001538								11404460	t		lperfetto	Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Here, we demonstrate that akt phosphorylates the androgen receptor (ar) at ser-210 and ser-790	SIGNOR-244136	0.2	
SIGNOR-PC	Prostate Cancer	PPARG	factor	protein	P37231	UNIPROT	HDAC1		protein	Q13547	UNIPROT	down-regulates	relocalization			9606									16431920	t		fspada	These data suggest that c/ebp beta activates a single unified pathway of adipogenesis involving its stimulation of ppargamma expression, which then activates c/ebp alpha expression by dislodging hdac1 from the promoter for degradation in the proteasome	SIGNOR-143961	0.616	
SIGNOR-PC	Prostate Cancer	AR		protein	P10275	UNIPROT	Differentiation	phenotypesList	phenotype	SIGNOR-PH37	SIGNOR	up-regulates				9606									15861399	f		miannu	AR homodimers recruit a panoply of factors including coactivators and mediator proteins whose enzymatic activities promote chromatin remodeling and transcriptional regulation of target genes leading to cell differentiation, survival, and proliferation	SIGNOR-251538	0.7	
SIGNOR-PC	Prostate Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	MDM2		protein	Q00987	UNIPROT	up-regulates activity	phosphorylation	Ser166	SSRRRAIsETEENSD	9606									15169778	t		lperfetto	Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylation.	SIGNOR-244296	0.2	
SIGNOR-PC	Prostate Cancer	HGF	extracellular	protein	P14210	UNIPROT	MET	receptor	protein	P08581	UNIPROT	up-regulates	binding			9606									8380735	t		gcesareni	Hgf is the ligand for p190met, the receptor tyrosine kinase encoded by the met proto-oncogene.	SIGNOR-38429	0.922	
SIGNOR-PC	Prostate Cancer	PIK3CA		protein	P42336	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity				9606		BTO:0000150							19573809	f		lperfetto	However, here we show through phosphoprotein profiling and functional genomic studies that many PIK3CA mutant cancer cell lines and human breast tumors exhibit only minimal AKT activation and a diminished reliance on AKT for anchorage-independent growth	SIGNOR-236436	0.785	
SIGNOR-PC	Prostate Cancer	FOXA1	factor	protein	P55317	UNIPROT	AR		protein	P10275	UNIPROT	down-regulates quantity by repression	transcriptional regulation			9606									24875621	t		miannu	FOXA1 directly inhibits AR expression and thus the transcription of its target genes.  FOXA1 inhibits AR gene expression in prostate cancer. oss of FOXA1 may lead to androgen-independent AR signaling and thus castration-resistant prostate cancer progression. Indeed, we have recently reported that FOXA1 is downregulated in CRPC	SIGNOR-251541	0.737	
SIGNOR-PC	Prostate Cancer	PIK3CA		protein	P42336	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation			9606									12167717	t		lperfetto	PKB induction requires phosphorylation of two critical residues, threonine 308 in the activation loop and serine 473 near the carboxyl terminus. Membrane localization of PKB was found to be a primary determinant of serine 473 phosphorylation. PI3K activity was equally important for promoting phosphorylation of serine 473,	SIGNOR-244429	0.785	
SIGNOR-PC	Prostate Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	MDM2		protein	Q00987	UNIPROT	up-regulates activity	phosphorylation	Ser188	RKRHKSDsISLSFDE	9606									15169778	t		lperfetto	Stabilization of mdm2 via decreased ubiquitination is mediated by protein kinase b/akt-dependent phosphorylationhere we show that pkb inhibits mdm2 self-ubiquitination via phosphorylation of mdm2 on ser(166) and ser(188)	SIGNOR-244300	0.2	
SIGNOR-PC	Prostate Cancer	PIP3	receptor	smallmolecule	CHEBI:16618	ChEBI	PDPK1		protein	O15530	UNIPROT	up-regulates activity	relocalization			9534									9637919	t		lperfetto	In response to PDGF, binding of ptdlns (3,4,5)p3 and/or ptdlns(3,4)p2 to the PH domain of PDK-1 causes its translocation to the plasma membrane where it co-localises with PKB, significantly contributing to the scale of PKB activation.	SIGNOR-58313	0.8	
SIGNOR-PC	Prostate Cancer	AR		protein	P10275	UNIPROT	NKX3-1	factor	protein	Q99801	UNIPROT	up-regulates quantity by expression	transcriptional regulation			9606									16697957	t		miannu	Whereas androgen receptor (AR) positively regulates NKX3.1 expression, NKX3.1 negatively modulates AR transcription and consequently the AR-associated signaling events.	SIGNOR-251546	0.463	
SIGNOR-PC	Prostate Cancer	AR		protein	P10275	UNIPROT	TMPRSS2	receptor	protein	O15393	UNIPROT	up-regulates quantity by expression	transcriptional regulation			9606									24505269	t		miannu	Recurrent gene fusion between the androgen-regulated gene TMPRSS2 and members of the ETS transcription factor family, most commonly ERG, are present in about 50% of prostate cancer cases. Presence of this fusion gene is a critical event in the development of prostate cancer. the more aggressive phenotype that arises with the presence of TMPRSS2-ERG at least in part is caused by changes in the tumor stroma.	SIGNOR-251545	0.55	
SIGNOR-PC	Prostate Cancer	NKX3-1	factor	protein	Q99801	UNIPROT	AR		protein	P10275	UNIPROT	down-regulates quantity by repression	transcriptional regulation			9606									16697957	t		miannu	Whereas androgen receptor (AR) positively regulates NKX3.1 expression, NKX3.1 negatively modulates AR transcription and consequently the AR-associated signaling events.	SIGNOR-251547	0.463	
SIGNOR-PC	Prostate Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606									15718470	t		gcesareni	Akt/PKB activation requires the phosphorylation of Thr308 in the activation loop by the phosphoinositide-dependent kinase 1 (PDK1) and Ser473 within the carboxyl-terminal hydrophobic motif by an unknown kinase.	SIGNOR-243203	0.787	
SIGNOR-PC	Prostate Cancer	MDM2		protein	Q00987	UNIPROT	TP53	factor	protein	P04637	UNIPROT	down-regulates quantity by destabilization	ubiquitination			9606									10935507	t		lperfetto	Many posttranslational modifications of p53, such as phosphorylation, dephosphorylation, acetylation and ribosylation, have been shown to occur following cellular stress. Some of these modifications may activate the p53 protein, interfere with MDM2 binding and/or dictate cellular localization of p53.	SIGNOR-80528	0.969	
SIGNOR-PC	Prostate Cancer	EZH2	factor	protein	Q15910	UNIPROT	AR		protein	P10275	UNIPROT	up-regulates activity	binding			9606									23239736	t		miannu	This study demonstrates that phosphorylation of EZH2 at Ser21, mediated directly or indirectly by the PI3K-Akt pathway, can switch its function from a Polycomb repressor to a transcriptional coactivator of AR (and potentially other factors).	SIGNOR-251542	0.52	
SIGNOR-PC	Prostate Cancer	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	EZH2	factor	protein	Q15910	UNIPROT	down-regulates activity	phosphorylation	Ser21	CWRKRVKsEYMRLRQ	9606									16224021	t		lperfetto	Enhancer of zeste homolog 2 (ezh2) is a methyltransferase that plays an important role in many biological processes through its ability to trimethylate lysine 27 in histone h3. Here, we show that akt phosphorylates ezh2 at serine 21 and suppresses its methyltransferase activity by impeding ezh2 binding to histone h3	SIGNOR-244259	0.2	
SIGNOR-PC	Prostate Cancer	PDPK1		protein	O15530	UNIPROT	AKT		proteinfamily	SIGNOR-PF24	SIGNOR	up-regulates activity	phosphorylation	Thr308	KDGATMKtFCGTPEY	9606		BTO:0000887;BTO:0001103;BTO:0001760							9512493	t		lperfetto	The activation of PKBbeta and PKBamma by PDK11 was accompanied by the phosphorylation of the residues equivalent to Thr308 in PKBalpha, namely Thr309 (PKBbeta) and Thr305 (PKBgamma)	SIGNOR-244480	0.787	
SIGNOR-PC	Prostate Cancer	NKX3-1	factor	protein	Q99801	UNIPROT	HDAC1		protein	Q13547	UNIPROT	down-regulates activity	binding			9606									16697957	t		miannu	NKX3.1 also binds HDAC1 and releases p53 from p53-MDM2-HDAC1 complex, promoting p53 acetylation and activity. 	SIGNOR-251549	0.383	
SIGNOR-PC	Prostate Cancer	ERG		protein	P11308	UNIPROT	MYC	factor	protein	P01106	UNIPROT	up-regulates quantity by expression	transcriptional regulation			9606									25277175	f		miannu	Increased expression of ERG or other ETS factors under control of androgen responsive promoter (TMPRSS2) is an inevitable consequence of the fusion events, and it activates transcriptional program that contributes to oncogenesis by upregulating expression of, among others, MYC, EZH2 and SOX9 and repressing NKX3.	SIGNOR-251554	0.279	
